The modern MSL role demands business acumen and digital agility. Those who insist they are "just here for the science" and resist using tools like CRM or AI will not be viable in the future. These skills are now core competencies, not optional extras, for driving impact in pharma.

Related Insights

Macroeconomic data does not support the fear that AI will eliminate marketing jobs. Instead, AI literacy is becoming a non-negotiable requirement for employment. Much like proficiency in Word and Excel became standard for office work, understanding and using AI tools is now a fundamental expectation for modern marketers.

To stay valuable, marketers must polarize their skills to either end of the spectrum. You must either be incredibly technical—able to deploy AI workflows like an engineer—or operate at the outer edges of creativity and storytelling. The 'good enough' skills of the messy middle will be automated away.

True success with AI won't come from blindly accepting its outputs. The most valuable professionals will be those who critically evaluate, customize, and go beyond the simple, default solutions offered by AI tools, demonstrating deeper thinking and unique value.

Traditional "value-based selling" is obsolete. In an AI-driven market, customers demand tangible, immediate results, not buzzwords. A sales rep's only true value is their deep product expertise—the ability to deploy the tool, troubleshoot, and demonstrate ROI firsthand. Reps who lack this are being bypassed in favor of those who can actually deliver.

AI requires senior marketing leaders to personally develop technical competencies. Simply delegating AI initiatives is a career-limiting move, as a new generation of marketers will soon combine creative strategy with deep technical 'growth architecture' skills and out-architect their campaigns.

Don't let fear of pushback from your sales team delay AI implementation. The transition will naturally filter your organization; reps who resist are likely underperformers you should let go, while top performers will embrace the tools to exceed their quotas.

Relying on relationships is an insufficient defense against AI in sales. Salespeople who can't answer tough technical objections and lack deep product knowledge are becoming obsolete. Expertise, not just charm, is the new requirement to provide value that an AI cannot.

The rise of AI tools isn't replacing the PM role, but transforming it. PMs who embrace an "AI-enhanced" workflow for research, docs, and prototyping will gain a massive productivity advantage, ultimately displacing those who stick to traditional methods.

The pace of AI development is too rapid to wait for a perfect integration strategy. The biggest mistake is inaction driven by fear. Salespeople should focus on experimenting and getting comfortable with AI tools now, as the cost of falling behind will be significant.

According to Immunocore's CEO, the biggest imminent shift in drug development is AI. The critical need is not for AI to replace scientists, but for a new breed of professionals fluent in both their scientific domain and artificial intelligence. Those who fail to adapt will be left behind.